PEPTIDE

Selank

Selank is a synthetic heptapeptide analog of the endogenous immunomodulatory peptide tuftsin, developed by the Russian Academy of Sciences. It delivers neuropeptide signaling research observations in non-clinical research contexts, modulating GABAergic signaling, stabilizing enkephalins, and upregulating BDNF to support mood stability, memory, and stress resilience.

Selank is a synthetic heptapeptide analog of the endogenous immunomodulatory peptide tuftsin, developed and extensively studied by the Institute of Molecular Genetics, Russian Academy of Sciences, for neuropsychiatric and cognitive research:

Core Mechanism & Key Properties

Modulates GABAergic signaling to reduce anxiety without sedation, cognitive impairment, or dependence risk (a critical distinction from benzodiazepine anxiolytics)
Stabilizes endogenous enkephalins to regulate mood and stress response, and upregulates brain-derived neurotrophic factor (BDNF) to support neuroplasticity, memory, and learning
Exerts mild immunomodulatory effects inherited from its parent peptide tuftsin
Has a favorable safety profile with no reported abuse potential or cognitive side effects in preclinical and early clinical research

Primary Research Applications

Anxiety and stress resilience research
Cognitive enhancement, memory, and neuroplasticity studies
Mood regulation and stress-related neuropsychiatric disorder models
Neuroimmune modulation and neuroprotective research

Manufactured to ≥99% purity, sterile-filtered, and lyophilized for long-term stability.

For laboratory research use only; not intended for human or veterinary administration.

Research use only: This material is supplied for laboratory research and documentation workflows only. It is not intended for human consumption, diagnostic use, therapeutic use, veterinary use or clinical application.

Hytan procurement and documentation support

For Selank, Hytan Peptides can support research-use sourcing review with available batch COA, vial labeling, product identity notes, storage documentation and wholesale quantity discussion. Product-specific CAS, sequence, molecular weight or method details should be confirmed against the current batch document before procurement decisions.

COA review: request batch-specific purity and identity references where available.
Wholesale planning: confirm vial strength, quantity, lead time, packing and destination requirements.
Compliance: research-use wording should remain clear in quote, invoice and receiving records.

Manufacturing Capability

Controlled production for consistent research peptide supply

Hytan Peptides supports wholesale research peptide orders with organized production workflow, clean handling, standardized filling, labeling and batch-level documentation. From material preparation to final review, each step is managed to support consistent appearance, traceable COA records and dependable supply coordination.

This production overview helps laboratories, distributors and qualified research buyers understand how Hytan Peptides approaches quality-focused peptide manufacturing, packaging and order readiness.